Andreas Kluge
Fondateur chez TELIX PHARMACEUTICALS LIMITED
Fortune : 222 M $ au 30/04/2024
Postes actifs de Andreas Kluge
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 03/01/2017 | - |
| Fondateur | 01/11/2015 | - | |
| Directeur Technique/Scientifique/R&D | 03/01/2017 | 02/06/2020 | |
Therapeia GmbH & Co. Kg
 Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Directeur Général | 01/01/2007 | - |
| Fondateur | 01/01/2007 | - | |
| Directeur Technique/Scientifique/R&D | 01/01/2007 | - | |
| ABX-CRO advanced pharmaceutical services | Directeur Technique/Scientifique/R&D | 01/08/2002 | - |
| Fondateur | 01/08/2002 | - |
Historique de carrière de Andreas Kluge
Anciens postes connus de Andreas Kluge
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ABX advanced biochemical compounds GmbH
 ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Directeur Général | 01/09/1996 | 01/07/2002 |
| Fondateur | 01/09/1996 | 01/07/2002 |
Formation de Andreas Kluge
| Freie Universität Berlin | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 5 |
| Australie | 2 |
Opérationnelle
| Founder | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Health Technology |
| ABX-CRO advanced pharmaceutical services | |
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Process Industries |
- Bourse
- Insiders
- Andreas Kluge
- Expérience
